About Tirupati Medicare Limited
Data last updated:
Tirupati Medicare Limited is a public limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 August 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2005PLC139667. Its GSTIN is 02AACCT2945A1ZZ (Himachal Pradesh). The company holds 5 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹2.51 Cr. It was formerly known as Tirupati Zeon Medicare Limited. It is led by directors including Dinesh Goyal (Managing Director) and Manjeet Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at D – 14 Iind Floor Preet Vihar, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,119.15 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net loss of ₹20.8 Cr (net margin -1.9%) and EBITDA of ₹52.18 Cr (EBITDA margin 4.7%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 12% over five years.
The company has about 784 employees on its provident fund (EPFO) records. Its group structure includes 3 subsidiaries.
The company is associated with 1 brand: Tirupati Medicare. As per MCA filings, the company has open charges of ₹207.41 Cr and satisfied charges of ₹245.31 Cr on record. Court records list 36 cases involving the company, including 24 filed by the company and 12 filed against it; 13 cases are pending. The company has 9 deals on record (4 funding rounds, 4 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹406.7 Cr; the latest was in March 2025. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Cipla Health Limited with revenue of ₹1,228.87 Cr. The company has 18 MSME Form 1 returns on record between 2019 and 2024, listing 3,387 overdue payments to 188 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tirupatigroup.co.in.
Company details
Contact details
Tirupati Medicare Limited's registered office is in New Delhi, Delhi. Its website is tirupatigroup.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressD – 14 Iind Floor Preet Vihar, New Delhi, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Tirupati Medicare Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Tirupati Medicare operates one associated brand: Tirupati Medicare. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products are manufactured under contract by Tirupati Medicare. | tirupatigroup.co.in |
Business activity
The main business activity of Tirupati Medicare is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Tirupati Medicare Limited, buy the company report.
Financials of Tirupati Medicare Limited
FY 2024 filings availableTirupati Medicare Limited reported revenue of ₹1,119.15 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 6% growth in the latest year. EBITDA rose 474% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹52.18 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹20.8 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.7% | ||||
| Net Profit Margin | -1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tirupati Medicare Limited, buy the company report.
Board of directors and KMP of Tirupati Medicare Limited
Tirupati Medicare Limited currently reports 8 directors and 1 key managerial person. 20 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manjeet Kumar | Director | 27 Sep 2023 | 3 Years 1 Months | Current |
| Bharti Sharma Also directs: Pontika Aerotech Limited | Director | 31 Mar 2024 | 2 Years 7 Months | Current |
| Ajay Goel | Director | 09 Nov 2005 | 20 Years 11 Months | Current |
| Rahul Dilip Shah Also directs: Neuberg Diagnostics Private Limited | Nominee Director | 26 Mar 2025 | 1 Years 7 Months | Current |
| Dinesh Goyal Also directs: Tirupati Technosoft LLP, Vidisha Tradex LLP, Vidisha Tradex Private Limited and 5 more | Managing Director | 26 Mar 2025 | 1 Years 7 Months | Current |
| Arun Goyal Also directs: Earth Aid Solutions LLP, Baba Shri Sham Developers LLP, Tirupati Technosoft LLP and 5 more | Director | 16 Aug 2005 | 21 Years 2 Months | Current |
Peer comparison
Tirupati Medicare Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cipla Health Limited | ₹1,228.87 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Neon Laboratories Limited | ₹1,222.81 Cr (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Corona Remedies Limited | ₹1,202.35 Cr (FY 2025) | 18.0% | Ahmedabad, Gujarat, India | |||
| Hetero Healthcare Limited | ₹1,189.8 Cr (FY 2025) | 16.0% | Hyderabad, Telangana, India | |||
| BDR Pharmaceuticals International Private Limited | ₹1,137.31 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| Tirupati Medicare Limitedthis company | ₹1,119.15 Cr (FY 2025) | -₹20.8 Cr | -1.9% | 6.0% | 784 | New Delhi, Delhi, India |
| Zuventus Healthcare Limited | ₹1,117.95 Cr (FY 2025) | 4.0% | Pune, Maharashtra, India | |||
| Medley Pharmaceuticals Limited | ₹1,114.92 Cr (FY 2025) | 8.0% | Mumbai, Maharashtra, India | |||
| Troikaa Pharmaceuticals Limited | ₹1,088.44 Cr (FY 2025) | 12.0% | Ahmedabad, Gujarat, India | |||
| Tenshi Pharmaceuticals Private Limited | ₹1,071.06 Cr (FY 2024) | 98.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Tirupati Medicare Limited, buy the company report.
Auditor
Tirupati Medicare Limited is audited by S.R. Batliboi & Co. LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.R. Batliboi & Co. LLP | FY 2023 | 301003E/E300005 |
Shareholding
The shareholding of Tirupati Medicare Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Tirupati Medicare Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Mar 2025 | 101095364 | Others | ₹5 Cr | Open | |
| 26 Mar 2025 | 101095363 | Others | ₹5 Cr | Open | |
| 11 Mar 2025 | 101070751 | Others | ₹25 Cr | Open | |
| 01 Feb 2023 | 100673387 | Others | ₹25 Cr | Open | |
| 23 Mar 2022 | 100553694 | Hdfc Bank Limited | ₹15 Cr | Open |
To see the full charge records of Tirupati Medicare Limited, buy the company report.
Total charge records: 22 View all charges
Deals & funding
Tirupati Medicare Limited has 9 deals on record (4 funding rounds, 4 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹406.7 Cr; the latest was in March 2025.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: International Cylinders Pvt Ltd, Maya Industries Limited |
| Jan 2012 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Sunil Kumar & Sons, Ashok Kumar & Sons, 2 individuals |
| Mar 2010 | Funding round | ₹1.2 Cr | Investors: Maya Industries Limited , 2 individuals |
| Mar 2008 | Funding round | ₹4.51 Cr | Investors: International Cylinders Pvt Ltd, 3 individuals |
To see the full deal history of Tirupati Medicare Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Tirupati Medicare Limited has 36 court cases on record: 24 filed by Tirupati Medicare, 12 filed against it. 13 cases are pending and 23 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 18 | 8 | 10 |
| High courts | 16 | 2 | 3 |
| Supreme Court | 2 | 2 | 0 |
Cases on record (5 of 36)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Sirmaur, Himachal Pradesh | Civil miscellaneous application | Filed against the company by Premedium Pharmaceuticals Pvt Ltd. Through S K Nigam | Pending |
| High Court of Delhi | Commercial suit | Filed against the company by Pulse Pharmaceuticals Pvt Ltd | Pending |
| High Court | Court case (COMIP) | Filed against the company by Aristo Pharmaceuticals Private Limited | Pending |
| District court, Sirmaur, Himachal Pradesh | Court case (Suit for Recovery) | Filed by the company against Premedium Pharmaceuticals Pvt Ltd | Pending |
| District court, Kurukshetra, Haryana | Civil suit | Filed by the company against Ravenbhel Health Care Private Ltd. and 2 others | Pending |
To see the full case history of Tirupati Medicare Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Tirupati Medicare Limited was last rated by Crisil on 19 Jun 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 19 Jun 2020 |
To see the full credit ratings and regulatory alerts of Tirupati Medicare Limited, buy the company report.
MSME payment delays
Tirupati Medicare Limited has 18 MSME Form 1 returns on record between 2019 and 2024, listing 3,387 overdue payments to 188 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 188)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Allied Sales Corporation | |||
| Caps (India) | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Tirupati Medicare Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Tirupati Medicare has 3 subsidiary companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Newtramax Healthcare Private Limited | U24111HP2020PTC008045 | |
| Tirupati Wellness Private Limited | U24299HP2020PTC008008 | |
| Tirupati Lifesciences Private Limited | U24299HP2020PTC008056 |
To see the full group structure of Tirupati Medicare Limited, buy the company report.
Employees & EPFO
Tirupati Medicare Limited has a workforce of 784 employees on its EPFO records as of May 18, 2024, across 1 active EPFO establishment.
GST
Tirupati Medicare has 5 GST registrations: 4 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AACCT2945A1ZZ | Himachal Pradesh | Active | 01 Jul 2017 |
| 27AACCT2945A1ZN | Maharashtra | Active | 09 Aug 2017 |
| 36AACCT2945A1ZO | Telangana | Active | 07 Apr 2022 |
| 21AACCT2945A1ZZ | Odisha | Active | 11 Apr 2022 |
To see the full GST registrations and return filing status of Tirupati Medicare Limited, buy the company report.
Recent activity
Tirupati Medicare Limited has 28 board changes on record since 2005: 10 appointments and 18 cessations. The latest: Madhvi Pahwa was appointed as Director on 30 Sep 2025.
60 earlier events are in the company report.
News
Frequently asked questions
Tirupati Medicare is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 August 2005 (21+ years old) and is registered under CIN U24233DL2005PLC139667.
Tirupati Medicare has 9 current directors and KMP:
- Dinesh Goyal - Managing Director
- Manjeet Kumar - Director
- Bharti Sharma - Director
- Ajay Goel - Director
- Rahul Dilip Shah - Nominee Director
- Arun Goyal - Director
- Sarbesh Kumar Das - Director
- Madhvi Pahwa - Director
- Ashok Goyal - Ceo
The latest financial statements of Tirupati Medicare on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Tirupati Medicare is 02AACCT2945A1ZZ, registered in Himachal Pradesh. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 27AACCT2945A1ZN (Maharashtra), 36AACCT2945A1ZO (Telangana), 21AACCT2945A1ZZ (Odisha).
The CIN (Corporate Identification Number) of Tirupati Medicare is U24233DL2005PLC139667. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tirupati Medicare has 36 court cases on record: 24 filed by the company and 12 filed against it. 13 are pending. Most are in the district courts.
Tirupati Medicare was incorporated on 16 August 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
Tirupati Medicare has 9 deals on record (4 funding rounds, 4 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹406.7 Cr; the latest was in March 2025.
The peers of Tirupati Medicare by revenue are Cipla Health Limited, Neon Laboratories Limited, Corona Remedies Limited, Hetero Healthcare Limited, BDR Pharmaceuticals International Private Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Madhvi Pahwa was appointed as Director on 30 Sep 2025. Ajay Goel ceased to be Director on 11 Jun 2025. Ashok Goyal ceased to be Director on 11 Jun 2025. Tirupati Medicare has 28 board changes on record in total.
Tirupati Medicare has 18 MSME Form 1 returns on record between 2019 and 2024, listing 3,387 overdue payments to 188 micro and small suppliers. The latest return was filed on 25 Apr 2024.
Tirupati Medicare can be reached through the website tirupatigroup.co.in. Its registered office is in New Delhi, Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
